Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Healthcare, Regulatory and Reimbursement Landscape SingaporeA low population growth rate and rising elderly population represent a challenge for the policy planners in Singapore
By: Rajesh Gunnam The pharmaceutical market in Singapore was estimated at $375m in 2010. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.6% and is projected to reach approximately $845m in 2020. The major factors contributing to the growth of Singapore’s pharmaceutical market include efficient intellectual property protection which is globally ranked one, excellent infrastructure including the development of a biomedical industrial park – Tuas Medical Park and the research centre, Biopolis. The government of Singapore also offers incentives to the multinational biomedical companies to establish their production and research units in the country. For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ The five types of healthcare insurance plans available in Singapore are Medisave, MediShield, Medisave- Approved Integrated Shield Plans, MediFund and ElderShield. A Medisave plan can be used to pay for a person’s own or immediate family member’s hospitalization, surgery and outpatient treatment expenses on payment of the premium. MediShield is a catastrophic medical insurance scheme, with features such as ‘deductibles’ To improve the global competitiveness of the country in the healthcare sector, the government of Singapore implemented several policies and health programs that improved the quality of life of patients and their health outcomes. One such policy is mainly focused on reducing the disease burden on the elderly population of Singapore. GlobalData, the industry analysis specialist, has released its report, “Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare market of Singapore. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Singapore. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com/ For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a global market intelligence services company providing information research and analysis products and services. End
|